Project Grant HT94252410681
Award Date 9/30/24
Completion Date 9/29/26
Dollars Obligated $320K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
- The federal Project Grant award, valued at $250,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Washington University's Office of Sponsored Research Services Division. The award will fund a study on the "SUBCLINICAL PATHOPHYSIOLOGY OF MOTOR PROCESSING IN PEOPLE WITH MULTIPLE SCLEROSIS" over a 2-year period from September 30, 2024 to September 29, 2026. As a prominent private research university, The...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $894,125 to The Washington University in University City, Missouri to conduct research titled "UNDERSTANDING AND TARGETING EPIGENETIC VULNERABILITIES IN NF-1-MPNST". The research aims to transform healthcare for military service members, veterans, and the public by advancing innovative medical solutions. The award period runs from July 15, 2025 to...
- This Project Grant award of $447,625.00 was provided by the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), to The Washington University located in University City, Missouri. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public, with a focus on developing innovative medical solutions that address critical health challenges. The research will be conducted at...
- This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $311,000.00 in funding to The Washington University in University City, Missouri. The award supports a 2-year research project using biomedical informatics and artificial intelligence to improve detection of degenerative cervical myelopathy, a neurological disorder. As a prominent private research university, The Washington University has extensive...
- This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
- The Johns Hopkins University was awarded a $980,943 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into PAAN/MIF nuclease inhibition for neuroprotection in multiple sclerosis from August 15, 2022 to August 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
- This federal Project Grant award of $319,999.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Maryland, Baltimore on the relationship between cortical lesions, meningeal inflammation, and Epstein-Barr virus infection in multiple sclerosis, as observed using 7-T MRI. The award period runs from November 1, 2024 to October 31, 2026. The research aims to advance understanding of the underlying...
- The Washington University in St. Louis School of Medicine was awarded a $933,911 project grant from the Department of the Army Medical Command on September 30, 2022. The grant is part of the Military Medical Research and Development program (CFDA 12.420) and will support basic, applied, and advanced biomedical research efforts through September 29, 2025. Specifically, the grant funding will enable research to transform healthcare for service members and the general public through innovative...
- The Washington University received a $236,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant funding supports research from July 1, 2021 to June 30, 2023 to study the role of blood-brain barrier dysfunction in epilepsy associated with tuberous sclerosis complex. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...